Clinical trial · Interventional
Multimodal Mobile Intervention Application (App) to Address Sexual Dysfunction in Hematopoietic Stem Cell Transplant Survivors
NCT03967379CI-TRIAL-00085499completedN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 26, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260926-000001
Summary
Brief summary (as posted)
This research study is being done to evaluate whether the use of a mobile app can help transplant survivors experiencing sexual health problems.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Other Cancer | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Enhanced Standard Care | Other | — | UNRESOLVED |
| Mobile App + enhanced standard care | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Mobile app plus enhanced standard care
- description
- * Patients will received enhanced standard care in addition to access to the sexual health mobile app. * The app will also prompt patients to engage their partners with specific exercises.
- interventionNames
- Behavioral: Mobile App + enhanced standard care
- Other: Enhanced Standard Care
- type
- OTHER
- label
- Enhanced Standard Care
- description
- * Patients will receive Enhanced Standard Care * Patients will meet with a transplant clinician for a brief medical examination to assess the need for medications for erectile dysfunction, vaginal atrophy, or vulvovaginal GVHD * Patients will not have access to the sexual health mobile app
- interventionNames
- Other: Enhanced Standard Care
Primary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Adult patients (≥18 years) who underwent an autologous or allogeneic HCT at least 3 months prior to study enrollment. * Ability to speak English or able to complete questionnaires with assistance required from an interpreter or family member. * Positive screen for sexual dysfunction that is causing distress based on the NCCN survivorship guidelines Exclusion Criteria: * Recurrent disease requiring treatment * Significant uncontrolled psychiatric disorder (psychotic disorder, bipolar disorder, major depression) or other co-morbid disease (dementia, cognitive impairment), which the treating clinician believes prohibits the ability to participate in study procedures.
References
Publications (1)
- DERIVEDMarkovitz NH, Traeger L, Vanderklish J, Horick N, Newcomb R, Larizza IS, Boardman AC, DeFilipp Z, Chen YB, Dizon DS, Reese JB, Temel J, Amonoo HL, El-Jawahri A. Sexual Health in Hematopoietic Stem Cell Transplantation Survivors. J Natl Compr Canc Netw. 2025 Jun 9;23(7):e257019. doi: 10.6004/jnccn.2025.7019. PMID 40490014